Acetaminophen, plasma or serum
Tylenol, Paracetamol
used for the quantitative analysis of acetaminophen in human serum or
plasma. The assay is based on competition between drug in the sample
and drug labeled with the enzyme glucose‑6‑phosphate dehydrogenase
(G6PDH) for antibody binding sites. Enzyme activity decreases upon
binding to the antibody, so the drug concentration in the sample can be
measured in terms of enzyme activity. Active enzyme converts oxidized
nicotinamide adenine dinucleotide (NAD+) to NADH, resulting in an
absorbance change that is measured spectrophotometrically. Endogenous
serum G6PDH does not interfere because the coenzyme functions only with
the bacterial (Leuconostoc mesenteroides) enzyme employed in the assay.
Serum, Plasma (Heparin)
150 uL
Acetaminophen is one of the most widely used analgesics on the market today. It is available in many formulations including liquid, tablets, capsules and suppositories. The chemical name is N-acetyl-p-aminophenol (APAP). Acetaminophen has an excellent safety profile in therapeutic doses, but hepatotoxicty can develop in overdose situations. Metabolism is primarily hepatic with the half life being 2 to 4 hours. The parent compound, acetaminophen is non-toxic, but the metabolite N-acetyl-benzoquinoneimine (NAPQI) is toxic. Normally, glutathione will bind the NAPQI and form a non-toxic conjugate which is excreted. In overdose situations, as glutatione stores are depleted, the NAPQI binds to the lipid bilayer of the hepatocytes resulting in necrosis. N-acetylcysteine (NAC) is an effective antidote.
Browse tests by laboratory
Customer Service
Toll Free: 1-855-381-3212
Local: 416-813-7200

